Pine Labs shares: Over 25% up in a month; Motilal Oswal sees 30% more upside | Buy rating - 'Monetization in motion'
AI Summary
Pine Labs' strong growth projections and the initiation of coverage by Motilal Oswal with a 'buy' rating signal a positive outlook for the company, particularly as it capitalizes on higher-margin transaction-led revenue streams. Retail investors should note the expected expansion of adjusted EBITDA margins and the potential impact of the new MDR on P2M transactions, which could enhance profitability. Given the recent recovery in share price, this could be an opportune moment for investors looking to capitalize on the fintech sector's growth trajectory in India.
Pine Labs shares: Brokerage firm Motilal Oswal has initiated coverage on merchant payment platform Pine Labs, assigning a ‘buy’ rating, saying ‘Monetization in motion’. The brokerage firm has given a target price of ₹250 per share, seeing upside potential of up to 30% from the current market price.
The firm expects the company to post a strong CAGR of 24% in revenue, 46% in adjusted EBITDA and 129% in adjusted PAT over FY26–FY28E. It also expects the adjusted EBITDA margin to expand significantly to 28.7%, from 9% in FY24.
Original Article
Published on Livemint
Frequently Asked Questions
What is this article about?
This is a market news update from Livemint, published on 23 September 2026.
Is this news positive or negative for markets?
TopFund's automated sentiment analysis reads this article as neutral in tone, based on the language used in the report. This is a general signal, not investment advice.
Where can I read the full article?
The full article is available at the original source, Livemint — see the "Read Original Article" link on this page.